Observe Medical finalizes subsequent offering to raise capital

Observe Medical ASA's board of directors has resolved to increase its share capital by issuing up to 24,000,000 new shares at a subscription price of NOK 0.50 each. This greenlights the subsequent offering, building on a private placement announced on June 11, 2025, that raised gross proceeds of NOK 36,445,000.

The subsequent offering is conditional upon the Norwegian Financial Supervisory Authority's (NFSA) approval of a prospectus. Approval is anticipated around September 25, 2025, with the subscription period expected from September 26, 2025, to October 10, 2025.

Eligible shareholders as of June 11, 2025, will receive subscription rights. Each right entitles them to subscribe for one offer share at NOK 0.50, and over-subscription is permitted. Allocation of offer shares is projected for October 13, 2025, with delivery by October 22, 2025. SB1 Markets AS is managing the offering.